Impact Factor
3.22
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.50
418 total citations
h5-index
23
h5 depth signal
Cited share
69.2%
119 of 172
Total citations
418
Citation footprint
Metric signal
2.60
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
763
Canada
41
Germany
30
United Kingdom
21
Switzerland
13
Citing Fields of Research
Brain Neurological Disorders
279
Nervous System Disorders
182
Neuromuscular Disorders
153
Neurodegenerative Disorders
126
Vascular Disorders
93
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,764
Articles tracked across the journal lifetime
Indexed publication set
172
119 cited publications
Last 12 months
78
7.1 publications/month
Open access share
14.1%
11 OA publications in the last year
Leading citing country
United States
763 citing publications
Leading citing field
Brain Neurological Disorders
279 citing publications
Latest tracked publication
28 August 2026
10 recent records available
Coverage & Indexing History
v6n1, 1986-
v6n1, 1986-
Active Coverage
Research Focus & Classification
Indexed Subjects
Brain Neurological Disorders
Nervous System Disorders
Neuromuscular Disorders
Vascular Disorders
Chronobiology
Neurodegenerative Disorders
Broad Categories
Neurology
Vascular Disorders
Brain Neurological Disorders
Musculoskeletal Disorders
Brain Imaging
Respiratory Support
Neuromuscular Disorders
MeSH Descriptors
Neurology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1055/a-2936-5945
Open DOI
Clinical Syndromes of Peripheral Nervous System Neurotoxicity from Immune-Checkpoint Inhibitors
The introduction of immune checkpoint inhibitors (ICIs) has dramatically changed the landscape of treatment for a variety of cancers. However, there is increasing recognition of neurotoxicity related to ICI use. In this review, we will d...
02
DOI 10.1055/a-2936-4931
Open DOI
Neurologic Complications of Cancer Immunotherapy
The use of oncologic-directed immunotherapies, including immune checkpoint inhibitors (ICIs) and chimeric antigen receptor T cell (CAR-T) therapy, has risen exponentially in recent years. Although these therapies have been shown to impro...
03
DOI 10.1055/a-2942-3475
Open DOI
Neuroimaging in Tremor
Neuroimaging has been used extensively to study tremors, providing invaluable information about the underlying mechanisms and applications to clinical practice. Although isolated tremor syndromes, such as essential tremor, are generally ...
04
DOI 10.1055/a-2936-3979
Open DOI
Equity in Neurotoxicity Care in the Era of Cancer Immunotherapy
Immunotherapies such as chimeric antigen receptor T cell (CAR-T) therapy and immune checkpoint inhibitors have improved cancer survival but are associated with potentially severe neurotoxicities that can impair neurologic function, quali...
05
DOI 10.1055/a-2928-7527
Open DOI
Neuro-Ophthalmic Manifestations of Immunotherapy Toxicity
Approximately half of the brain subsumes visual function, so neurologic toxicities of immunotherapy medications may frequently manifest with visual symptoms. As the use of immunotherapeutic medicines proliferates for a broader array of i...
06
DOI 10.1055/a-2893-7436
Open DOI
Non-stenotic Carotid Disease: Review of the Literature and Case Discussion of TCAR for Treatment
Non-stenotic carotid disease represents an understudied yet clinically significant pathology. While stenosis is the primary mechanism underlying most strokes, other mechanisms such as thromboembolism from plaque rupture and carotid webs ...
07
DOI 10.1055/a-2870-6009
Open DOI
Isolated Cranial Tremors: A Reappraisal
Isolated cranial tremors (face tremor, jaw tremor, vocal tremor, and embouchure tremor) are unusual examples of focal tremor disorders. The etiology and treatment of these troublesome and occasionally disabling conditions deserve more at...
08
DOI 10.1055/a-2873-5461
Open DOI
Dystonia and Tremor
Dystonia and tremor are common movement disorders with heterogenous presentations. Their overlap, termed “tremor in dystonia” for this review, is a common phenomenon that is classified inconsistently in practice and the literature. While...
09
DOI 10.1055/a-2848-9343
Open DOI
Pendular Nystagmus and Oculopalatal Tremor
Acquired pendular nystagmus consists of quasi-sinusoidal oscillations of the eyes that significantly impair gaze stability and visual clarity. It most commonly occurs in demyelinating disorders such as multiple sclerosis and in acquired ...
10
DOI 10.1055/a-2877-5952
Open DOI
Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Vol. 14, no. 4 (DEC 1994)19950520 Notice not published Printed on acid-free paper